MedPath

The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis

Phase 2
Conditions
Ulcerative Colitis
Fecal Microbiota Transplantation
Interventions
Biological: Fecal Microbiota Transplantation
Registration Number
NCT02435160
Lead Sponsor
Jun Liu
Brief Summary

The aim of our study is to investigate the efficacy and mechanism in fecal microbiota transplantation in the treatment of ulcerative colitis. About 20 Ulcerative Colitis (UC) patients will be recruited into our trial for Fecal Microbiota Transplantation (FMT) treatment,the safety and efficacy of FMT will be observed.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • mild to moderate UC patients
  • male
  • volunteered to our FMT trial
Exclusion Criteria
  • severe UC
  • Hb < 6g/dL

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Ulcerative ColitisFecal Microbiota Transplantation-
Primary Outcome Measures
NameTimeMethod
Change of mayo criteria in UC patients after FMT.one year
Number of patients with adverse events after FMT.one year
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath